Late saphenous vein graft occlusion remains a significant clinical problem without effective surgical or pharmacological preventive strategies, highlighting the need to understand underlying mechanisms like smooth muscle cell proliferation.
Answers are grounded in this paper and cite their sources.
Late saphenous vein graft occlusion lacks proven preventive strategies; leaves open mechanistic research into smooth muscle proliferation.
Occlusion of saphenous vein coronary artery bypass grafts remains a significant clinical problem. Early occlusion can be minimized by optimizing surgical techniques and by antithrombotic treatments. Unfortunately, no modification of surgical technique or drug therapy has been shown to reduce late vein graft occlusion. This results from excessive proliferation of vascular smooth muscle cells and the superimposition of atheroma on the resulting thickened intima. Understanding the basic mechanisms underlying this response may be helpful in developing strategies to reduce vein graft occlusion.
No takes yet. Share an insight, caveat, or question.
Gianni D. Angelini (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: